Synonyms:
Status: Phase 1
Entry Type: Antibody
Molecule Category: UNKNOWN
UNII: 2OP4E0GC6V

Pharmacology

Action Mechanism of Action Reference
ANTAGONIST HLA-DR antigens-associated invariant chain antagonist PubMed
Primary Target
CD74

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Leukemia, Lymphocytic, Chronic, B-Cell 1 D015451 ClinicalTrials
Lymphoma 1 D008223 ClinicalTrials
Multiple Myeloma 1 D009101 ClinicalTrials
Plasmacytoma 1 D010954 ClinicalTrials

Cross References

Resources Reference
CAS NUMBER 899796-83-9
ChEMBL CHEMBL1743040
FDA SRS 2OP4E0GC6V
Guide to Pharmacology 8267